IHE holdings -what the fund actually owns
iShares U.S. Pharmaceuticals ETF reports 56 stock positions to the SEC, 100% of its assets. The ten largest are 76.1% of the fund, as of Jun 30, 2026.
Each week Ploutos reads the latest N-PORT filing of the largest US equity ETFs. This page is one fund's filing: its reported positions with their weights, where that weight sits by sector, what entered and left since the previous filing, and which other funds hold the most of the same stocks.
- Reported positions
- 56
- cover 100% of the fund
- Weight of the top 10 holdings
- 76.1%
- Largest position
- JNJ
- 22.44% · JOHNSON & JOHNSON
- Filing date
- Jun 30, 2026
- holdings as reported to the SEC
Where the weight sits, by sector
- Healthcare95.5%
- Unknown3.0%
- Basic materials1.4%
Sectors come from each company's industry code in its SEC record, so they are coarse. 3.0% of the reported weight could not be placed and is shown as unknown.
Full holdings list, heaviest first
- JNJJOHNSON & JOHNSONWeight22.44%
- LLYELI LILLY AND COMPANYWeight22.25%
- MRKMERCK & CO., INC.Weight4.55%
- BMYBRISTOL-MYERS SQUIBB COMPANYWeight4.37%
- RPRXROYALTY PHARMA PLCWeight4.34%
- VTRSVIATRIS INC.Weight4.22%
- PFEPFIZER INC.Weight3.96%
- ZTSZOETIS INC.Weight3.73%
- JAZZJAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANYWeight3.45%
- ELANELANCO ANIMAL HEALTH INCORPORATEDWeight2.81%
- AXSMAXSOME THERAPEUTICS, INC.Weight2.42%
- CORTCORCEPT THERAPEUTICS INCORPORATEDWeight1.90%
- LGNDLIGAND PHARMACEUTICALS INCORPORATEDWeight1.45%
- DFTXDefinium Therapeutics IncWeight1.39%
- LQDALiquidia CorpWeight1.28%
- INDIVIOR PHARMACEUTICALS, INC.No pageWeight1.14%
- Crinetics Pharmaceuticals IncNo pageWeight0.90%
- OGNORGANON & CO.Weight0.81%
- EWTXEdgewise Therapeutics IncWeight0.70%
- AMRXAMNEAL PHARMACEUTICALS, INC.Weight0.68%
- ELVNEnliven Therapeutics IncWeight0.63%
- SUPERNUS PHARMACEUTICALS, INC.No pageWeight0.62%
- TARSTarsus Pharmaceuticals IncWeight0.57%
- MANEVeradermics IncWeight0.56%
- ALMSAlumis IncWeight0.55%
- NKTRNEKTAR THERAPEUTICSWeight0.54%
- PBHPRESTIGE CONSUMER HEALTHCARE INC.Weight0.51%
- TRVITrevi Therapeutics IncWeight0.50%
- OCULOCULAR THERAPEUTIX, INC.Weight0.39%
- INVAINNOVIVA, INC.Weight0.36%
- AMLXAmylyx Pharmaceuticals IncWeight0.35%
- ANIPANI PHARMACEUTICALS, INC.Weight0.34%
- MBXMBX Biosciences IncWeight0.34%
- HRMYHARMONY BIOSCIENCES HOLDINGS, INC.Weight0.33%
- PRGOPERRIGO COMPANY PUBLIC LIMITED COMPANYWeight0.33%
- HROWHARROW, INC.Weight0.32%
- NUVBNUVATION BIO INC.Weight0.32%
- XERSXERIS BIOPHARMA HOLDINGS, INC.Weight0.31%
- RAPPRapport Therapeutics IncWeight0.27%
- COLLCollegium Pharmaceutical, Inc.Weight0.27%
- EYPTEYEPOINT, INC.Weight0.26%
- AtaiBeckley IncNo pageWeight0.23%
- PCRXPACIRA BIOSCIENCES, INC.Weight0.23%
- WVEWAVE Life Sciences LtdWeight0.20%
- MAZEMaze Therapeutics IncWeight0.19%
- LBRXLB Pharmaceuticals IncWeight0.18%
- BIOABIOAGE Labs IncWeight0.18%
- SEPNSepterna IncWeight0.18%
- AMPHAMPHASTAR PHARMACEUTICALS, INC.Weight0.16%
- OMEROMEROS CORPORATIONWeight0.16%
| Stock | Weight | Cumulative |
|---|---|---|
| JNJJOHNSON & JOHNSON | 22.44% | 22.4% |
| LLYELI LILLY AND COMPANY | 22.25% | 44.7% |
| MRKMERCK & CO., INC. | 4.55% | 49.2% |
| BMYBRISTOL-MYERS SQUIBB COMPANY | 4.37% | 53.6% |
| RPRXROYALTY PHARMA PLC | 4.34% | 57.9% |
| VTRSVIATRIS INC. | 4.22% | 62.2% |
| PFEPFIZER INC. | 3.96% | 66.1% |
| ZTSZOETIS INC. | 3.73% | 69.9% |
| JAZZJAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY | 3.45% | 73.3% |
| ELANELANCO ANIMAL HEALTH INCORPORATED | 2.81% | 76.1% |
| AXSMAXSOME THERAPEUTICS, INC. | 2.42% | 78.5% |
| CORTCORCEPT THERAPEUTICS INCORPORATED | 1.90% | 80.4% |
| LGNDLIGAND PHARMACEUTICALS INCORPORATED | 1.45% | 81.9% |
| DFTXDefinium Therapeutics Inc | 1.39% | 83.3% |
| LQDALiquidia Corp | 1.28% | 84.5% |
| INDIVIOR PHARMACEUTICALS, INC.No page | 1.14% | 85.7% |
| Crinetics Pharmaceuticals IncNo page | 0.90% | 86.6% |
| OGNORGANON & CO. | 0.81% | 87.4% |
| EWTXEdgewise Therapeutics Inc | 0.70% | 88.1% |
| AMRXAMNEAL PHARMACEUTICALS, INC. | 0.68% | 88.8% |
| ELVNEnliven Therapeutics Inc | 0.63% | 89.4% |
| SUPERNUS PHARMACEUTICALS, INC.No page | 0.62% | 90.0% |
| TARSTarsus Pharmaceuticals Inc | 0.57% | 90.6% |
| MANEVeradermics Inc | 0.56% | 91.1% |
| ALMSAlumis Inc | 0.55% | 91.7% |
| NKTRNEKTAR THERAPEUTICS | 0.54% | 92.2% |
| PBHPRESTIGE CONSUMER HEALTHCARE INC. | 0.51% | 92.7% |
| TRVITrevi Therapeutics Inc | 0.50% | 93.2% |
| OCULOCULAR THERAPEUTIX, INC. | 0.39% | 93.6% |
| INVAINNOVIVA, INC. | 0.36% | 94.0% |
| AMLXAmylyx Pharmaceuticals Inc | 0.35% | 94.3% |
| ANIPANI PHARMACEUTICALS, INC. | 0.34% | 94.7% |
| MBXMBX Biosciences Inc | 0.34% | 95.0% |
| HRMYHARMONY BIOSCIENCES HOLDINGS, INC. | 0.33% | 95.4% |
| PRGOPERRIGO COMPANY PUBLIC LIMITED COMPANY | 0.33% | 95.7% |
| HROWHARROW, INC. | 0.32% | 96.0% |
| NUVBNUVATION BIO INC. | 0.32% | 96.3% |
| XERSXERIS BIOPHARMA HOLDINGS, INC. | 0.31% | 96.6% |
| RAPPRapport Therapeutics Inc | 0.27% | 96.9% |
| COLLCollegium Pharmaceutical, Inc. | 0.27% | 97.2% |
| EYPTEYEPOINT, INC. | 0.26% | 97.4% |
| AtaiBeckley IncNo page | 0.23% | 97.7% |
| PCRXPACIRA BIOSCIENCES, INC. | 0.23% | 97.9% |
| WVEWAVE Life Sciences Ltd | 0.20% | 98.1% |
| MAZEMaze Therapeutics Inc | 0.19% | 98.3% |
| LBRXLB Pharmaceuticals Inc | 0.18% | 98.5% |
| BIOABIOAGE Labs Inc | 0.18% | 98.7% |
| SEPNSepterna Inc | 0.18% | 98.8% |
| AMPHAMPHASTAR PHARMACEUTICALS, INC. | 0.16% | 99.0% |
| OMEROMEROS CORPORATION | 0.16% | 99.1% |
Funds that hold the most of the same stocks
The share of IHE that is also in each fund, from the positions both report.
- PPHVanEck Pharmaceutical ETFOverlap43.7%
- XLVState Street(R) Health Care Select Sector SPDR(R) ETFOverlap37.0%
- IYHiShares U.S. Healthcare ETFOverlap36.5%
- VHTVANGUARD HEALTH CARE INDEX FUNDOverlap32.7%
- IXJiShares Global Healthcare ETFOverlap26.0%
- HDViShares Core High Dividend ETFOverlap10.7%
- QLTYGMO U.S. Quality ETFOverlap8.5%
- VIGVANGUARD DIVIDEND APPRECIATION INDEX FUNDOverlap8.1%
| Fund | Overlap | Shared |
|---|---|---|
| PPHVanEck Pharmaceutical ETF | 43.7% | 13 |
| XLVState Street(R) Health Care Select Sector SPDR(R) ETF | 37.0% | 7 |
| IYHiShares U.S. Healthcare ETF | 36.5% | 13 |
| VHTVANGUARD HEALTH CARE INDEX FUND | 32.7% | 52 |
| IXJiShares Global Healthcare ETF | 26.0% | 7 |
| HDViShares Core High Dividend ETF | 10.7% | 3 |
| QLTYGMO U.S. Quality ETF | 8.5% | 3 |
| VIGVANGUARD DIVIDEND APPRECIATION INDEX FUND | 8.1% | 4 |
What are the top holdings of IHE?
Its filing lists 56 stock positions. The largest are JNJ 22.4%, LLY 22.2%, MRK 4.5%, and the ten largest together are 76.1% of the fund. The full list with weights is on this page.
How many stocks are in IHE?
IHE reports 56 stock positions in its SEC filing of Jun 30, 2026, and together they are 100% of the fund. Cash, futures and bonds the fund holds are not counted.
How do I check whether IHE holds a particular stock?
Search the full list on this page by ticker or company name, for example NVDA or Nvidia. A stock the fund holds shows with its weight and its rank in the fund. If it does not show, the fund did not report it as a position in this filing.
How often do these holdings change?
Funds report their positions to the SEC at each quarter end, and the SEC publishes the filing about 60 days later. Ploutos reads the latest one every week, so the page changes four times a year, and shows the date of the filing it reads.
Why does the coverage not reach 100%?
The list is the stock positions the fund reports. Cash, futures, bonds and other assets the filing carries are not listed, and what the stocks add up to is the coverage shown. A stock fund lands near 100; a fund that holds futures or a cash sleeve lands lower. Weights are of the whole fund.
Related pages
Descriptive data from public SEC filings. Holdings change between filings.